Seed Round

A new platform powered by a 51%-returning AI firm aims to slash fund launch costs by 98%, potentially unleashing a new wave of financial entrepreneurs.

The American Diabetes Association is funding seven visionary scientists using AI, CRISPR, and stem cells to forge the next frontier in diabetes treatment.

With a new $9.5M facility from SVB, Realta Fusion is accelerating its unique magnetic mirror tech to bring on-site, carbon-free power to heavy industry.

New platform feature makes AI analysis fully traceable, tackling the 'black box' problem to build trust and accelerate high-stakes financial decisions.

With new CEO John Slaven, MineSense aims to scale its ore-sorting tech globally, tackling the urgent need for sustainable critical mineral supplies.

Gaxos.ai secures a deal with ByteDance's BytePlus, gaining access to elite AI video models to challenge giants in the booming creator content market.

Amidst a volatile stock history, GT Biopharma aims to secure vital funding for its innovative NK cell therapy pipeline at a key Toronto conference.

Tech titans like Micron, NVIDIA, and Applied Materials join forces in a $2.5B alliance to forge India into a global deep tech powerhouse.

With its expansion to Europe and LATAM, Halper AI and its founder are betting on a radical idea: the best AI is the one you never have to open.

Iterum Therapeutics secures key Medicare access for its antibiotic ORLYNVAH™, but a costly FDA trial requirement for a new use casts a shadow on its future.

A Taiwanese whisky distributor is betting big on AI with $120M in proposed deals, raising questions of genius, risk, and the frenzy of the AI gold rush.

A new 68-unit affordable senior community in Castle Hayne is secured by a key federal loan, highlighting a successful model for rural housing needs.

With its first dedicated private credit fund, Brigade Capital is targeting a complex, underserved market segment to deliver what larger lenders often miss.

Blue Cross and MassChallenge award five startups $50k each to solve critical health disparities, from endometriosis diagnosis to language access in hospitals.

A new paint from Adept Materials uses advanced physics to passively regulate indoor humidity, promising healthier homes and lower energy bills.

YBI's new 'Landing Zone' program offers a free, equity-free path for manufacturing startups, leveraging world-class expertise to enter the US market.

The tech giant behind Evernote and Vimeo is launching a massive scholarship, a strategic play to secure Europe's top computer science innovators.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

With a new flexible, founder-first model, Activation Capital's Frontier BioHealth program aims to bridge the commercialization gap for life sciences startups.

Delonix Bioworks' next-gen meningitis B vaccine, DX-104, is cleared for human trials in China and Australia, aiming to challenge the market leaders.